InvestorPlace - Stock Market News, Stock Advice & Trading Tips
CARA stock results show that Cara Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
The post CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace